Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
Company Continues Rapid Growth and Eyes Further Expansion in 2014
ATLANTA, Oct. 29, 2013 /PRNewswire/ -- The fastest growing medical technology company in the United States announced the receipt of multiple awards today. Following the launch of the Fuse™ system, EndoChoice® has received multiple awards within the last month linked to the rapid growth of the company's revenue and global expansion. EndoChoice received the Hire Power Award by Inc. Magazine, was selected as one of HealthCare's Hottest Companies by Modern HealthCare Magazine and earned recognition from Excellence in Surgical Products for innovative visualization technology.
Earlier in 2013, EndoChoice was highlighted as the fastest growing medical technology company in the world by analysts reviewing growth rates within the industry. Since being founded in 2008, EndoChoice has grown from two employees to almost 400, while maintaining a compounded annual revenue growth rate of more than 100%, essentially doubling every year since being founded. The continued success of the company has brought the attention of industry watchers such as Inc. Magazine, Modern HealthCare Magazine and Excellence in Surgical Products.
The demand for the revolutionary Fuse endoscopy system by gastroenterologists around the world is leading to more expansion plans for EndoChoice in 2014 and beyond. New endoscopes and expanded capabilities to augment the Fuse system are in development. But the growth is spread across the broad portfolio of GI products and services developed by EndoChoice.
"While the launch of Fuse is certainly exciting, we continue to grow our base businesses in devices, infection control and pathology at rates unheard of within the industry," said Mark Gilreath, Founder, President and CEO. "We are here to serve the GI care giver so they can provide the best possible care to their patients. By remaining singularly focused on the GI platform, we find deeper insights into the needs of our customers. Our growth is positive feedback that we're doing the right things."
Based in Atlanta, EndoChoice is a platform GI company that provides devices, diagnostics, infection control and imaging for specialists treating a wide range of gastrointestinal diseases. EndoChoice currently has over 2,000 customers and distribution in 34 countries worldwide, and has been recognized for four consecutive years as one of the fastest growing companies in the U.S. by Inc. Magazine. To learn more, visit www.endochoice.com.
EndoChoice® and Fuse™ are trademarks of EndoChoice®, Inc.
For more information, press only:
Doug Ladd, Chief Marketing Officer
513-608-6873 or Doug.Ladd@endochoice.com
For more information on
©2012 PR Newswire. All Rights Reserved.
Can't find what you're looking for?